Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience-Reference-Cited by-同舟云学术

Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience

Published:2020 Issue: Volume:75 Page:
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:

Author:

da Silva Wellington Fernandes,da Rosa Lidiane Inês,Seguro Fernanda Salles,Silveira Douglas Rafaele Almeida,Bendit Israel,Buccheri Valeria,Velloso Elvira Deolinda Rodrigues Pereira,Rocha Vanderson,Rego Eduardo M

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Guidelines on the management of acute myeloid leukaemia in adults;British Committee for Standards in Haematology;Br J Haematol,2006

2. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults;Pulte;Int J Cancer,2016

3. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges;Shallis;Blood Rev,2019

4. Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013;Song;Acta Haematol,2018

5. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience;Benicio;Leuk Res,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia – A propensity-score matching analysis;Journal of Medical Mycology;2023-11

2. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine;Haematologica;2023-03-23

3. Increasing access to allogeneic hematopoietic cell transplant: an international perspective;Hematology;2021-12-10

4. A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports;Frontiers in Oncology;2021-12-09

5. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?;Leukemia & Lymphoma;2020-09-30